Drug Type Small molecule drug |
Synonyms |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists), M3 receptor agonists(Muscarinic acetylcholine receptor M3 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H27NO4S |
InChIKeyVGXACJMXDYPFDB-SXMMONRFSA-N |
CAS Registry149926-91-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Phase 2 | EU | - | - |
Pulmonary Disease, Chronic Obstructive | Phase 2 | - | - | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | EU | - | - |
Pulmonary Disease, Chronic Obstructive | Phase 1 | - | - |